1142192-55-9 Usage
Uses
Used in Organic Synthesis:
Methyl 5-bromo-3-methoxypicolinate is used as a synthetic intermediate for the preparation of a range of organic compounds. Its unique structure, which includes a bromine atom and a methoxy group, makes it a versatile building block in the synthesis of complex organic molecules.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, Methyl 5-bromo-3-methoxypicolinate is employed as a key component in the development of pharmaceuticals. Its potential biological activities are being explored for therapeutic applications, making it a valuable asset in the discovery and design of new drugs.
Used in Research and Development:
Methyl 5-bromo-3-methoxypicolinate is utilized in research and development settings to study its potential applications and to understand its interactions with biological systems. This knowledge aids in the advancement of pharmaceutical and chemical research, contributing to the innovation of new products and processes.
Used in Industrial Applications:
Methyl 5-bromo-3-methoxypicolinate is also used in various industrial applications where its unique chemical properties are leveraged to enhance the performance of products or processes. Its availability from chemical suppliers supports the industrial demand for Methyl 5-bromo-3-methoxypicolinate in diverse sectors.
Check Digit Verification of cas no
The CAS Registry Mumber 1142192-55-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,4,2,1,9 and 2 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1142192-55:
(9*1)+(8*1)+(7*4)+(6*2)+(5*1)+(4*9)+(3*2)+(2*5)+(1*5)=119
119 % 10 = 9
So 1142192-55-9 is a valid CAS Registry Number.
1142192-55-9Relevant academic research and scientific papers
1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS
-
Paragraph 00238, (2021/08/06)
Compounds according to formula I or II are useful as agonists of Toll-like receptor 7 (TLR7). Such compounds can be used in cancer treatment, especially in combination with an anti-cancer immunotherapy agent, or as a vaccine adjuvant.
HETEROARYL SUBSTITUTED HETEROCYCLYL SULFONES
-
Page/Page column 88, (2015/11/09)
The invention relates to aryl substituted heterocyclyl sulfones as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
